Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 5 | 2019 | 263 | 0.860 |
Why?
|
| Platelet Function Tests | 1 | 2020 | 10 | 0.720 |
Why?
|
| Thromboembolism | 1 | 2020 | 91 | 0.690 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2018 | 5 | 0.650 |
Why?
|
| Intracranial Aneurysm | 1 | 2020 | 87 | 0.640 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 150 | 0.610 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 373 | 0.600 |
Why?
|
| Hematoma, Subdural | 1 | 2014 | 19 | 0.470 |
Why?
|
| beta-Alanine | 1 | 2014 | 20 | 0.460 |
Why?
|
| Antithrombins | 1 | 2014 | 32 | 0.460 |
Why?
|
| Benzimidazoles | 1 | 2014 | 128 | 0.430 |
Why?
|
| Decision Making | 1 | 2014 | 410 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 1026 | 0.360 |
Why?
|
| Valproic Acid | 2 | 2021 | 93 | 0.350 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 93 | 0.350 |
Why?
|
| Anticoagulants | 2 | 2020 | 356 | 0.300 |
Why?
|
| Intestinal Diseases | 1 | 2007 | 25 | 0.290 |
Why?
|
| Piperidines | 1 | 2007 | 123 | 0.270 |
Why?
|
| Narcotic Antagonists | 1 | 2007 | 184 | 0.260 |
Why?
|
| Naltrexone | 1 | 2007 | 195 | 0.250 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2013 | 21 | 0.210 |
Why?
|
| Intracranial Hypertension | 2 | 2013 | 53 | 0.200 |
Why?
|
| Intensive Care Units | 3 | 2019 | 344 | 0.200 |
Why?
|
| Hemorrhage | 2 | 2020 | 328 | 0.190 |
Why?
|
| Cefoxitin | 1 | 2020 | 20 | 0.180 |
Why?
|
| Warfarin | 1 | 2020 | 93 | 0.180 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2020 | 22 | 0.180 |
Why?
|
| Cerebral Ventriculitis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Drug Interactions | 1 | 2020 | 289 | 0.170 |
Why?
|
| Cerebrospinal Fluid | 1 | 2019 | 23 | 0.170 |
Why?
|
| Hypoalbuminemia | 1 | 2019 | 9 | 0.170 |
Why?
|
| Meningitis | 1 | 2019 | 23 | 0.170 |
Why?
|
| Anticonvulsants | 1 | 2021 | 223 | 0.170 |
Why?
|
| Pharmacokinetics | 1 | 2019 | 14 | 0.170 |
Why?
|
| Serum Albumin | 1 | 2019 | 104 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 37 | 0.160 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 102 | 0.160 |
Why?
|
| Humans | 16 | 2021 | 68549 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2020 | 1615 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.130 |
Why?
|
| Tobramycin | 2 | 2019 | 38 | 0.130 |
Why?
|
| Creatinine | 2 | 2020 | 243 | 0.130 |
Why?
|
| Aminoglycosides | 2 | 2019 | 54 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2020 | 7268 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2020 | 7028 | 0.130 |
Why?
|
| Mannitol | 2 | 2013 | 25 | 0.120 |
Why?
|
| Thrombelastography | 1 | 2014 | 19 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 2356 | 0.120 |
Why?
|
| Dabigatran | 1 | 2014 | 35 | 0.120 |
Why?
|
| Brain Edema | 1 | 2013 | 50 | 0.110 |
Why?
|
| Brain Injuries | 2 | 2013 | 268 | 0.110 |
Why?
|
| Middle Aged | 4 | 2020 | 21119 | 0.100 |
Why?
|
| Manganese Poisoning | 1 | 2011 | 3 | 0.100 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2011 | 22 | 0.100 |
Why?
|
| Diuretics, Osmotic | 1 | 2011 | 5 | 0.100 |
Why?
|
| Eclampsia | 1 | 2011 | 16 | 0.100 |
Why?
|
| Half-Life | 1 | 2010 | 96 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2011 | 239 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2010 | 164 | 0.090 |
Why?
|
| Patient Care | 1 | 2010 | 61 | 0.090 |
Why?
|
| Aged | 3 | 2020 | 14842 | 0.090 |
Why?
|
| Adult | 4 | 2020 | 21379 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 248 | 0.090 |
Why?
|
| Ventilator Weaning | 1 | 2009 | 27 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 377 | 0.080 |
Why?
|
| Male | 5 | 2020 | 37283 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 142 | 0.080 |
Why?
|
| Ileus | 1 | 2007 | 7 | 0.070 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2007 | 20 | 0.070 |
Why?
|
| Gastrointestinal Transit | 1 | 2007 | 16 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 848 | 0.070 |
Why?
|
| Female | 5 | 2020 | 38021 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4843 | 0.060 |
Why?
|
| Young Adult | 2 | 2011 | 5710 | 0.050 |
Why?
|
| Intracranial Pressure | 2 | 2013 | 58 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 498 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2021 | 46 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 23 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2020 | 44 | 0.050 |
Why?
|
| Hypertension | 1 | 2010 | 1533 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 80 | 0.050 |
Why?
|
| Critical Illness | 2 | 2013 | 191 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2019 | 50 | 0.040 |
Why?
|
| Stroke | 1 | 2012 | 2162 | 0.040 |
Why?
|
| Gentamicins | 1 | 2019 | 68 | 0.040 |
Why?
|
| Vancomycin | 1 | 2019 | 60 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 334 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 567 | 0.030 |
Why?
|
| American Heart Association | 1 | 2012 | 142 | 0.020 |
Why?
|
| Manganese | 1 | 2011 | 26 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 411 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 65 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2011 | 44 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2011 | 107 | 0.020 |
Why?
|
| Medicine | 1 | 2011 | 51 | 0.020 |
Why?
|
| Heart Valves | 1 | 2012 | 171 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1055 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 239 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 689 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2004 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 2334 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2222 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 2176 | 0.010 |
Why?
|
| United States | 1 | 2012 | 7338 | 0.010 |
Why?
|